Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2025

Jan 7, 2025

32414_dirs_2025-01-06_c9d340ba-085c-469a-843a-d61ab2ca81a6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2024-12-31

Reporting Person: TYNDALL JOSEPH A. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-08-08 Common Stock P 2525 $10.50 Acquired 25082 Direct

Footnotes

F1: Discloses an inadverent failure to report a purchase by the individual made in 2024.